Long-Term Outcomes Following Hypoxic Ischemic Encephalopathy.

Area of Science:

• Neonatal neurology
• Perinatal medicine
• Pediatric critical care

Background:

• Hypoxic ischemic encephalopathy (HIE) is a leading cause of neonatal encephalopathy, resulting in substantial morbidity and mortality.
• Long-term consequences of HIE include impairments across all developmental domains.
• Therapeutic hypothermia (TH) has demonstrated improved outcomes for term and late preterm infants with moderate to severe HIE.

Purpose of the Study:

• To review the current status and ongoing research of therapeutic hypothermia (TH) for hypoxic ischemic encephalopathy (HIE).
• To explore the potential of TH in mild or preterm HIE cases.
• To assess the efficacy of adjuvant therapies combined with TH for improving long-term outcomes in HIE.

Main Methods:

• Review of existing clinical trials and research on therapeutic hypothermia for HIE.
• Analysis of ongoing studies investigating TH for mild or preterm HIE.
• Evaluation of evidence for adjuvant therapies used in conjunction with TH.

Main Results:

• Therapeutic hypothermia (TH) has shown benefits for moderate to severe HIE in term and late preterm infants.
• Evidence supporting TH for mild or preterm HIE is still under investigation.
• Currently, no adjuvant therapies combined with TH have proven to improve long-term outcomes in HIE.

Conclusions:

• Therapeutic hypothermia is an established treatment for moderate to severe HIE in specific neonatal populations.
• Further research is necessary to establish the role of TH in mild/preterm HIE.
• Ongoing trials are exploring novel adjuvant therapies to enhance HIE treatment efficacy.